Useful resources |
Bisphosphonates for breast cancer (Cochrane Review) ABSTRACT Background: Bone is the most common site of metastatic disease associated with breast cancer affecting more than half of women during the course of their disease. Bisphosphonates, which inhibit osteoclast-mediated bone resorption, are standard care for tumour-as . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |